INY-03-041 trihydrochloride
Product Specifications
Target
Akt, PROTACs
Related Pathways
Cytoskeletal Signaling, PROTAC, PI3K/Akt/mTOR signaling
Bioactivity
INY-03-041 trihydrochloride, a potent and highly selective PROTAC-based pan-AKT degrader, comprises Ipatasertib, an ATP-competitive AKT inhibitor, conjugated to Lenalidomide. It effectively inhibits AKT1, AKT2, and AKT3 with IC50 values of 2.0, 6.8, and 3.5 nM, respectively [1].
Molecular Formula
C44H59Cl4N7O5
Molecular Weight
907.8
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB2316-100 1x 100 µL
Cdk2 / p34cdc2 Serine-Threonine Kinase (AN4.3), 0.2mg/mL
Sign In for Pricing
View Details 
TP701411 50 µg
Prothrombin (F2) (NM_000506) Human Recombinant Protein
Sign In for Pricing
View Details 
BNC040376-100 1x 100 µL
Beta Catenin (p120) (Rabbit PAb), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 